Thermo Fisher Scientific (TMO)
EBITDA
$2.51B
Quarterly · Period ending: · USD
TMO EBITDA
Latest reported$2.51Bperiod ending
Latest reported$2.51Bperiod ending
TMO Quarterly EBITDA ($63.10M → $2.51B)
Quarterly EBITDA
High-resolution chart · PNG
TMO ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 63,750,000 | |
| 62,452,000 | |
| 74,664,000 | |
| 65,513,000 | |
| 59,388,000 | |
| 77,871,000 | |
| 73,728,000 | |
| 11,100,000 | |
| 95,038,000 | |
| 106,237,000 | |
| 78,656,000 | |
| 121,100,000 | |
| 142,100,000 | |
| 146,000,000 | |
| 130,600,000 | |
| 156,900,000 | |
| 152,400,000 | |
| 98,400,000 | |
| 98,800,000 | |
| 87,300,000 | |
| 78,100,000 | |
| 62,100,000 | |
| 56,900,000 | |
| 73,900,000 | |
| 68,400,000 | |
| 57,700,000 | |
| 47,400,000 | |
| 53,400,000 | |
| 46,900,000 | |
| 42,800,000 | |
| 36,900,000 | |
| 38,000,000 | |
| 39,600,000 | |
| 23,500,000 | |
| 36,700,000 | |
| 18,600,000 | |
| 24,000,000 | |
| 17,000,000 | |
| 8,700,000 | |
| 9,100,000 | |
| 9,100,000 | |
| 9,300,000 | |
| 9,200,000 | |
| 13,900,000 | |
| 13,500,000 | |
| 6,600,000 | |
| 9,300,000 | |
| 7,000,000 | |
| 6,200,000 | |
| 150,800,000 | |
| 137,200,000 | |
| -331,100,000 | |
| 125,600,000 | |
| 121,400,000 | |
| 103,200,000 | |
| -297,500,000 | |
| 109,100,000 | |
| 95,500,000 | |
| 93,200,000 | |
| -230,800,000 | |
| 85,200,000 | |
| 79,700,000 | |
| 78,300,000 | |
| -191,400,000 | |
| 63,100,000 |